» Articles » PMID: 36446585

Establishment and Application of a Novel Model of Microglial Activation in Traumatic Brain Injury

Overview
Journal J Neurosci
Specialty Neurology
Date 2022 Nov 29
PMID 36446585
Authors
Affiliations
Soon will be listed here.
Abstract

Mechanical impact-induced primary injury after traumatic brain injury (TBI) leads to acute microglial pro-inflammatory activation and consequently mediates neurodegeneration, which is a major secondary brain injury mechanism. However, the detailed pathologic cascades have not been fully elucidated, partially because of the pathologic complexity in animal TBI models. Although there are several TBI models, none of them closely mimic post-TBI microglial activation. In the present study, we aimed to establish an TBI model, specifically reconstituting the pro-inflammatory activation and associated neurodegeneration following TBI. We proposed three sets of experiments. First, we established a needle scratch injured neuron-induced microglial activation and neurodegeneration model of TBI. Second, we compared microglial pro-inflammatory cytokines profiles between the TBI model and TBI in male mice. Additionally, we validated the role of injured neurons-derived damage-associated molecular patterns in amplifying microglial pro-inflammatory pathways using the TBI model. Third, we applied the model for the first time to characterize the cellular metabolic profile of needle scratch injured-neuron-activated microglia, and define the role of metabolic reprogramming in mediating pro-inflammatory microglial activation and mediated neurodegeneration. Our results showed that we successfully established a novel TBI model, which closely mimics primary neuronal injury-triggered microglial pro-inflammatory activation and mediated neurodegeneration after TBI. This model provides an advanced and highly translational platform for dissecting interactions in the pathologic processes of neuronal injury-microglial activation-neuronal degeneration cascade, and elucidating the detailed underlying cellular and molecular insights after TBI. Microglial activation is a key component of acute neuroinflammation that leads to neurodegeneration and long-term neurologic outcome deficits after TBI. However, it is not feasible to truly dissect primary neuronal injury-induced microglia activation, and consequently mediated neurodegeneration Furthermore, there is currently lacking of TBI models closely mimicking the TBI primary injury-mediated microglial activation. In this study, we successfully established and validated a novel TBI model of microglial activation, and for the first time, characterized the cellular metabolic profile of microglia in this model. This novel microglial activation TBI model will help in elucidating microglial inflammatory activation and consequently associated neurodegeneration after TBI.

Citing Articles

Deciphering microglial activation and neuronal apoptosis post‑traumatic brain injury: The role of TYROBP in inflammation regulation networks.

Zhou X, Song H, He J, Han W, Li Q Mol Med Rep. 2024; 29(6).

PMID: 38639190 PMC: 11063751. DOI: 10.3892/mmr.2024.13228.


The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy.

Liu X, Zhang Y, Zhao Y, Zhang Q, Han F Neurosci Bull. 2024; 40(5):621-634.

PMID: 38564049 PMC: 11127907. DOI: 10.1007/s12264-024-01193-3.


Tracing the path of disruption: C isotope applications in traumatic brain injury-induced metabolic dysfunction.

Peper C, Kilgore M, Jiang Y, Xiu Y, Xia W, Wang Y CNS Neurosci Ther. 2024; 30(3):e14693.

PMID: 38544365 PMC: 10973562. DOI: 10.1111/cns.14693.


The application of mesenchymal stem cells in the treatment of traumatic brain injury: Mechanisms, results, and problems.

Zhang Y, Zheng Z, Sun J, Xu S, Wei Y, Ding X Histol Histopathol. 2024; 39(9):1109-1131.

PMID: 38353136 DOI: 10.14670/HH-18-716.


Approbation of a New Model of Secondary Damage after Traumatic Brain Injury Based on Reprogrammed Rat Embryo Fibroblasts.

Rykunova E, Mikeladze M, Utepova I, Chupakhin O, Guzhova I, Lazarev V Dokl Biochem Biophys. 2023; 511(1):235-239.

PMID: 37833611 PMC: 10575796. DOI: 10.1134/S1607672923700345.


References
1.
Bae Y, Joo H, Bae J, Hyeon S, Her S, Ko E . Brain injury induces HIF-1α-dependent transcriptional activation of LRRK2 that exacerbates brain damage. Cell Death Dis. 2018; 9(11):1125. PMC: 6232134. DOI: 10.1038/s41419-018-1180-y. View

2.
Frankowski J, Tierno A, Pavani S, Cao Q, Lyon D, Hunt R . Brain-wide reconstruction of inhibitory circuits after traumatic brain injury. Nat Commun. 2022; 13(1):3417. PMC: 9197933. DOI: 10.1038/s41467-022-31072-2. View

3.
Covington N, Duff M . Heterogeneity Is a Hallmark of Traumatic Brain Injury, Not a Limitation: A New Perspective on Study Design in Rehabilitation Research. Am J Speech Lang Pathol. 2021; 30(2S):974-985. DOI: 10.1044/2020_AJSLP-20-00081. View

4.
Enriquez P, Bullock R . Molecular and cellular mechanisms in the pathophysiology of severe head injury. Curr Pharm Des. 2004; 10(18):2131-43. DOI: 10.2174/1381612043384060. View

5.
van Gastel N, Spinelli J, Sharda A, Schajnovitz A, Baryawno N, Rhee C . Induction of a Timed Metabolic Collapse to Overcome Cancer Chemoresistance. Cell Metab. 2020; 32(3):391-403.e6. PMC: 8397232. DOI: 10.1016/j.cmet.2020.07.009. View